Articles: sars-cov-2.
Showing all 10,751 articles tagged:
Sars-cov-2
-
Wien. Klin. Wochenschr. · Dec 2021
12-month SARS-CoV-2 antibody persistency in a Tyrolean COVID-19 cohort.
Short-term antibody response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been shown previously. The further development remains to be determined. ⋯ There was a persisting antibody response against SARS-CoV‑2 up to 12 months after COVID-19 with declining concentrations except for RBD and a strong increase of all antibody concentrations after vaccination.